Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sunee Neesanun"'
Autor:
Thanate Dajsakdipon, Thiti Susiriwatananont, Concord Wongkraisri, Suthinee Ithimakin, Napa Parinyanitikul, Archara Supavavej, Arunee Dechaphunkul, Patrapim Sunpaweravong, Sunee Neesanun, Charuwan Akewanlop, Thitiya Dejthevaporn, TSCO Breast Oncology Group
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The current standard first-line treatment for hormone receptor-positive/human epidermal growth factor receptor 2 negative (HR + /HER2 −) advanced breast cancer (ABC) is a combination of aromatase inhibitor (AI) plus CDK4/6 inhib
Externí odkaz:
https://doaj.org/article/5b0a3d9bcc4b42bca28dd69de26ddc68
Autor:
Sitthi Sukauichai, Kulthida Maneenil, Archara Supavavej, Vinai Paul, Duangnapa Benjawongsathien, Chaichana Chantharakhit, Sunee Neesanun, Chawalit Chayangsu, Thissawan Bowornkitiwong, Napawan Sukaraphat
Publikováno v:
Asian Pacific Journal of Cancer Care, Vol 7, Iss 4, Pp 643-650 (2022)
Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have been the standard of care as first-line (1L) therapy for patients with advanced EGFR mutated lung cancer since 2009. In Thailand, however, it was not fully introd
Externí odkaz:
https://doaj.org/article/f4d678ef918549a6a170769464fba9e1
Autor:
Sunee Neesanun
Publikováno v:
Asian Pacific Journal of Cancer Care, Vol 7, Iss 2, Pp 285-293 (2022)
Introduction: Chemotherapy-induced severe neutropenia requires dose reduction, delay in treatment, or discontinuation, and induces neutropenic complications resulting in poor outcomes and increased healthcare costs. This study aims to identify the ri
Externí odkaz:
https://doaj.org/article/9ff37d6e632342f9b0f0ebbc15f049e0
Autor:
Napawan Sukaraphat, Thissawan Bowornkitiwong, Chawalit Chayangsu, Sunee Neesanun, Chaichana Chantharakhit, Duangnapa Benjawongsathien, Vinai Paul, Archara Supavavej, Kulthida Maneenil, Sitthi Sukauichai
Publikováno v:
Asian Pacific Journal of Cancer Care. 7:643-650
Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have been the standard of care as first-line (1L) therapy for patients with advanced EGFR mutated lung cancer since 2009. In Thailand, however, it was not fully introd
Background Survival after diagnosis of brain metastases in non-small cell lung cancer (NSCLC) patients was dismal even after local therapy (surgery or brain irradiation), partly because of the systemic burden. Paucities of medical oncologists and mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26543c77432a13774e4fd9726a072e71
https://doi.org/10.21203/rs.3.rs-2324452/v1
https://doi.org/10.21203/rs.3.rs-2324452/v1
Autor:
Virote Sriuranpong, Sunee Neesanun
Publikováno v:
Journal of Clinical Oncology. 33:e19099-e19099
e19099 Background: Bone is a common metastasis site in advance stage NSCLC and a half of them occurred skeleton related event. Although the sensitivity of bone scan is quite high, its specificity i...